NCT05707403View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 14, 2023

Primary Completion Date

March 28, 2023

Study Completion Date

March 28, 2023

Conditions
Healthy
Interventions
DRUG

BI 1015550

Treatment T

DRUG

BI 1015550 mixed with [C-14]-BI 1015550

Treatment R

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY